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OBJECTIVES The goal of this study was to describe the clinical outcomes of patients undergoing cardiac
catheterization while supported with extracorporeal membrane oxygenation (ECMO).
BACKGROUND Extracorporeal membrane oxygenation is an important mechanical support for the failing
circulation. There are diagnostic and therapeutic indications for cardiac catheterization in
patients on ECMO, but no large series has been reported.
METHODS We performed a retrospective review of the indications and outcomes of patients catheterized
on ECMO from a single, large pediatric tertiary care center.
RESULTS At our institution, 192 patients with cardiac disease have undergone a total of 216 courses of
ECMO; 60 catheterizations were performed on 54 patients (28%). Indications for catheter-
ization included assessment of surgical repair (21 patients), left heart decompression (12
patients), myocarditis/cardiomyopathy assessment (10 patients), non-post-operative hemo-
dynamic assessment (8 patients), planned catheter-based interventions (6 patients), and
arrhythmia ablation (3 patients). An intervention was undertaken either during or after 50 of
the catheterizations (83%); 29 occurred at catheterization, 17 in the operating room (OR),
and 4 both during catheterization and in the OR. Complications during catheterization were
two myocardial perforations that were treated with pericardial drains (3%). Overall outcomes
included successful decannulation of 39 patients, survival to hospital discharge of 26 (48%)
patients, and longer-term survival of 23 (43%) patients (median follow-up, 35 months; range,
1 to 180 months). Fifteen patients were withdrawn from ECMO support due to severe
neurologic impairment or lack of myocardial recovery.
CONCLUSIONS Cardiac catheterization can be performed safely on patients supported with ECMO.
Catheterization during ECMO enables the diagnosis of residual lesions and can facilitate
important therapeutic interventions. (J Am Coll Cardiol 2002;40:1681–6) © 2002 by the
American College of Cardiology Foundation
Extracorporeal membrane oxygenation (ECMO) has been
established as an important mechanical support for the
failing circulation in children with heart disease (1–5).
Accepted indications for ECMO in cardiac patients include
low cardiac output, unexpected cardiac arrest, failure to
wean from cardiopulmonary bypass (CPB), disproportional
cyanosis, and refractory arrhythmias (5). Survival of cardiac
patients on ECMO has improved since it was first reported
in the early 1970s (6,7). From 1986 to January 2002, the
cumulative international survival to discharge for cardiac
patients supported with ECMO was 39% (8). Outcomes
vary between institutions for a variety of reasons, but over
the same time period at our institution, the cumulative
survival to discharge for cardiac patients supported with
ECMO was 54%.
Previous descriptions of catheterization during ECMO
have been limited to single case reports (9–11) and small
series of patients (12,13). Butler et al. (9) reported the use of
ECMO to support a neonate with critical aortic stenosis
during balloon valvotomy. Ward et al. (10) reported
ECMO support during pulmonary artery stenting, and
Ward et al. (11) described left heart decompression on
ECMO with a long introducer across the atrial septum.
Ettedgui et al. (12) described a series of nine patients
undergoing catheterization while on ECMO where the
primary procedure performed in six of these patients was
balloon or blade atrial septostomy. Diagnostic catheteriza-
tion was performed on the other three patients. The survival
rate was 33%, including two patients transplanted within a
week of catheterization. desJardins et al. (13) described 15
patients undergoing catheterization on ECMO. Interven-
tions included four procedures at catheterization (three coil
embolizations and one atrial septostomy) and four opera-
tions. The survival to discharge of these patients was 29%,
and 14% (two patients) were alive at follow-up (43 and 73
months). These studies report patients from an earlier era of
ECMO. As the use of ECMO to support the circulation
after cardiac surgery has increased (8), so has the potential
utility for diagnostic and therapeutic advantages of cardiac
catheterization on ECMO. The purpose of this study is to
describe our institution’s experience with catheterization on
ECMO, including indications for catheterization, subse-
quent interventions, and clinical outcomes.
METHODS
We retrospectively reviewed the medical records of all
patients with known cardiac disease supported with ECMO
at Children’s Hospital Boston. Patients who underwent
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cardiac catheterization while supported by ECMO were
selected for further review. Patient characteristics identified
included age and weight at the time of catheterization and
anatomical cardiac diagnoses. The patients’ courses were
documented including indications for ECMO and cathe-
terization, any prior procedures, duration of time from
ECMO cannulation to catheterization, and catheterization
findings and subsequent interventions (catheter-based
and/or operative). Patient outcomes were categorized as
successful decannulation from ECMO (including cardiac
transplantation), survival to hospital discharge and during
follow-up, or withdrawal from ECMO support. Any com-
plications from the catheterization or during the transport
to and from the catheterization laboratory were recorded.
RESULTS
Between December 1984 and November 2001, 192 patients
were supported with a total of 216 courses of ECMO for
cardiac indications. Sixty catheterizations were performed
on 54 of these patients (28%). Six patients underwent two
catheterizations while supported with ECMO. The median
age at catheterization was 22 days (range, 1 day to 36 years),
and the median weight at catheterization was 4.3 kg (range,
1.9 to 81.5 kg). The anatomical diagnoses varied widely but
included 24 patients with two-ventricle physiology who
underwent 27 catheterizations, 14 patients with single-
ventricle physiology who underwent 14 catheterizations,
and 16 patients with varying types of cardiomyopathies who
underwent 19 catheterizations (Table 1).
Indications for ECMO. There were 56 courses of ECMO
in the 54 patients. Two patients were supported with a
second course of ECMO and underwent catheterization
during both ECMO runs. Venoarterial ECMO was per-
formed for 54 of 56 courses with either percutaneous
cannulation from the neck or femoral vessels, or transtho-
racic cannulation of the right atrium and ascending aorta
through an open sternum. Venovenous ECMO with can-
nulation via the internal jugular vein was initiated on two
patients with both pulmonary and cardiac disease. The
indications for ECMO included low cardiac output in 31
patients (55%), sudden cardiac arrest in 13 (23%), hypox-
emia in 6 (11%), failure to wean from CPB in 4 (7%), and
refractory arrhythmias in 2 patients (4%). The median time
from ECMO cannulation to catheterization was 1 day
(range, 0 to 11 days).
Indications for catheterization on ECMO. The indica-
tions for catheterization during the ECMO course are
shown in Table 2. Patients with structural heart disease who
acutely deteriorated, either during post-operative recovery
or independent of surgery, were catheterized for a detailed
hemodynamic assessment. Catheterizations to assess dilated
cardiomyopathy or myocarditis were limited to pulmonary
capillary wedge pressure measurement, coronary angiogra-
phy, and possible endomyocardial biopsy. Planned catheter-
based interventions were follow-up procedures on patients
with lesions identified at prior catheterization during
ECMO or just before ECMO, when interventions were
initially deferred due to patient instability. Left heart de-
compressions were limited procedures to relieve left atrial
hypertension in patients with left heart dysfunction. All
catheterized patients had undergone prior transthoracic
echocardiographic imaging, which was either suboptimal for
diagnosis or suggested significant lesions amenable to ther-
apeutic catheterization. Transesophageal echocardiography
was infrequently used before catheterization on ECMO
because of concerns regarding patient size, acuity, and risk
of trauma to the upper gastrointestinal tract in anticoagu-
lated patients.
Only one catheterization was performed in the intensive
care unit (ICU). This adult-sized patient with Ebstein’s
anomaly was urgently placed on ECMO in the catheteriza-
tion laboratory because of acute deterioration and cardiac
arrest. Catheterization in the ICU using transesophageal
echocardiographic guidance was performed to occlude an
Abbreviations and Acronyms
CPB  cardiopulmonary bypass
ECMO  extracorporeal membrane oxygenation
ICU  intensive care unit
OR  operating room
SVT  supraventricular tachycardia
Table 1. Cardiac Diagnoses of Patients Catheterized on ECMO
Two-ventricle physiology (n  24)
Transposition of the great arteries 7
Tetralogy of Fallot 6
Ebstein’s anomaly 3
Coarctation/pulmonary hypertension 3
Peripheral pulmonary stenosis 2
Other 3
Single-ventricle physiology (n  14)
Hypoplastic left heart variant 8
Hypoplastic right ventricle 4
Complex heterotaxy 2
Cardiomyopathy (n  16)
Acute myocarditis/endocarditis 6
Progressive dilated cardiomyopathy 5
Post-heart transplant 3
Restrictive cardiomyopathy 2
ECMO  extracorporeal membrane oxygenation.




Assessment of operative result 21 (35%)
Percutaneous left heart decompression 12 (20%)
Myocarditis/cardiomyopathy assessment 10 (17%)
Hemodynamic assessment (non-postoperative) 8 (13%)
Planned catheter-based interventions 6 (10%)
Arrhythmia mapping and ablation 3 (5%)
ECMO  extracorporeal membrane oxygenation.
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atrial septal defect with a device. Two patients were placed
on ECMO in the catheterization laboratory before the start
of the catheterization. One patient had decompensated
during transport to the catheterization laboratory and was
stabilized with ECMO before the procedure. The second
patient was electively transported to the catheterization
laboratory for ECMO cannulation and left atrial vent
placement with fluoroscopic guidance. All other patients
were transported to the catheterization laboratory on
ECMO. No patient was decannulated in the catheterization
laboratory, and all were subsequently transferred back to the
ICU or directly to the operating room (OR).
Post-operative catheterization on ECMO. Twenty-five
patients (46%) underwent 27 catheterizations on ECMO
(two patients were catheterized twice) within 10 days of a
surgical procedure. The median time from surgery to
cannulation in these patients was one day (range, 0 to 8
days), and the median time to catheterization after cannu-
lation was three days (range, 0 to 11 days). The surgical
procedures included tetralogy of Fallot repair (n  5), stage
1 Norwood palliation (n 5), arterial switch operation (n
3), Senning/Rastelli operation (n  3), heart transplant
(n  3), Fontan (n  2), coarctation repair (n  1),
bidirectional Glenn shunt (n  1), Senning operation (n 
1), truncus arteriosus repair (n  1), and Blalock-Taussig
shunt (n  1). Twenty-one of these 25 post-operative
patients (84%) underwent catheterization to assess the
quality of the surgical repair; four of these patients had
echocardiograhic findings of a residual lesion, nine patients
were suspected of having residual lesions based on hemo-
dynamic parameters measured in the ICU, and eight pa-
tients were catheterized for unexplained persistent myocar-
dial dysfunction with failure to wean from ECMO after
72 h of support.
The three heart transplant patients had severe biventricu-
lar dysfunction immediately after transplant, and catheter-
ization was pursued in these patients to assess hemodynam-
ics and perform an endomyocardial biopsy for possible acute
rejection. One post-operative patient with isolated left
ventricular dysfunction and arrhythmias after a Senning/
Rastelli operation went to catheterization for percutaneous
placement of a left atrial vent to decompress the left heart.
The same patient underwent a second catheterization on
ECMO to place a pulmonary artery catheter to monitor
pulmonary capillary wedge pressures during ECMO wean-
ing. The other post-operative patient who was catheterized
twice underwent diagnostic catheterization followed by an
interventional procedure (coil closure of a ventricular septal
defect) the following day.
Left heart decompression on ECMO. Twelve catheter-
izations were performed on 11 patients primarily for left
heart decompression (left atrial vent or atrial septal stent
placement). These procedures were performed in the setting
of persistent left atrial and ventricular dilation as assessed by
echocardiography, or persistent pulmonary edema on chest
radiograph after initiation of venoarterial ECMO. Eight of
these patients were supported with ECMO for cardiomy-
opathies with severe ventricular dysfunction. One patient
with cardiomyopathy had been supported with two separate
courses of ECMO and underwent left heart decompression
during both courses. The remaining three patients who
underwent left heart decompression included the post-
operative patient with left ventricular dysfunction after a
Senning/Rastelli procedure, a newborn with critical aortic
stenosis with persistent left atrial and ventricular distention
after balloon valvotomy, and a patient with acute thrombo-
sis of a mitral valve.
Arrhythmia ablation on ECMO. Two newborn patients
with severe Ebstein’s anomaly and refractory arrhythmias
underwent catheterization for radiofrequency catheter abla-
tion on ECMO. The first patient had frequent episodes of
supraventricular tachycardia (SVT) associated with severe
hypotension that were resistant to multiple antiarrhythmic
medications. She was placed on ECMO in the ICU to
support her circulation during arrhythmia stimulation for
intracardiac mapping and ablation in the catheterization
laboratory. She underwent ablation of a Mahaim fiber and
was successfully decannulated four days later. She remains
free of tachycardia at follow-up. The second patient was
diagnosed in utero with SVT. Post-natally, she was severely
hypoxemic while in SVT and was emergently placed on
ECMO. Her SVT was refractory to medical management,
and she also underwent a transcatheter ablation procedure.
The tachycardia was terminated initially with the first
ablation but recurred several hours later. After a second
ablation the following day, there was no recurrence of the
SVT, and she was successfully decannulated. However, she
died of multi-system organ failure and sepsis within a week
of decannulation.
Repeat catheterization after ECMO resuscitation. Eight
patients were placed on ECMO support after cardiac
catheterization, three were urgently resuscitated with
ECMO in the catheterization laboratory, and five were
placed on ECMO in the ICU for acute clinical deteriora-
tion. Four of these patients returned to catheterization to
complete planned interventions, and three patients underwent
follow-up catheterization to reassess their hemodynamics. The
remaining patient returned to catheterization for left heart
decompression.
Subsequent interventions. Interventions were performed
based on findings at 50 of the 60 catheterizations on
ECMO (83%). Figure 1 shows the type of catheterization
performed over time. Twenty-nine catheterizations involved
interventions performed in the laboratory. Seventeen pa-
tients underwent operative interventions, and four patients
underwent interventions both at catheterization and in the
OR. Twelve of the 21 patients catheterized to assess the
operative result underwent revision of the repair (57%), and
eight patients underwent initial surgical intervention after
catheterization on ECMO. Subsequent interventions are
detailed in Table 3. After the 21 operative interventions,
seven patients (33%) remained on ECMO or were transi-
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tioned back to ECMO support after CPB. One patient
(5%) was withdrawn from support in the OR after failure to
wean from CPB. The remaining 13 patients (62%) were
successfully weaned from CPB or ECMO support before
leaving the OR.
Complications. The complications observed during 60
catheterizations were limited to two myocardial perforations
(3%). One perforation occurred through the left atrial
appendage during a transseptal procedure to place a stent to
decompress the left heart in a patient with critical aortic
stenosis. The second perforation was presumed to be
through the left ventricular free wall in a diagnostic cathe-
terization in a patient with anomalous left coronary artery
and a congenital diaphragmatic hernia. Both patients were
newborns weighing less than 3.5 kg. Both patients were
treated with pericardial drains without surgical intervention
and survived the procedure. The patient with aortic stenosis
was successfully decannulated and is alive at follow-up.
There were no bleeding complications from the catheter-
izations. There were no transport-related complications of
the ECMO circuit to or from the catheterization laboratory.
Outcomes. After catheterization, 39 of 54 patients (72%)
were decannulated successfully (including six transplanted
from ECMO), 26 (48%) patients survived to discharge, and
23 (43%) patients are alive at follow-up (median follow-up,
35 months; range, 1 to 180 months). Fifteen (28%) patients
were withdrawn from ECMO due to severe neurological
impairment or lack of myocardial recovery. Withdrawal
from ECMO occurred a median of five days (range, 0 to 7
days) after catheterization. These patients were not consid-
ered to be transplant candidates either due to neurologic
injury, multi-system organ dysfunction, or family prefer-
ence. Figure 2 demonstrates the survival of patients cathe-
terized on ECMO over time. The survival to discharge
improved from 36% (4 of 11 patients surviving) during the
early experience before 1994, to 44% (4 of 9 patients
surviving) from 1994 to 1997, to 56% (19 of 34 patients
surviving) during the most recent experience from 1998 to
2001. Our most recent experience of catheterization on
ECMO (1998 to 2001) represents the majority of the
catheterizations performed (65%).
DISCUSSION
The outcomes of patients in this series suggest that cardiac
catheterization can be performed with minimal risk during
ECMO and that catheterization often yields information
that enables therapeutic interventions. The previously pub-
lished series by Ettedgui et al. (12) and desJardins et al. (13)
described the feasibility of cardiac catheterization of patients
supported by ECMO. Approximately half of these cath-
eterizations were diagnostic, with the majority of the
catheter-based interventions performed being a balloon or
blade atrial septostomy. In contrast with these earlier
experiences, the majority of our catheterization procedures
led to subsequent patient interventions, and our survival
Figure 1. Type of cardiac catheterization performed on extracorporeal
membrane oxygenation (ECMO) over time. “Interventional” refers to all
other interventions performed at catheterization other than endomyocar-
dial biopsy (EMB) and left atrium (LA) decompression. Striped bars 
EMB; dotted bars  LA decompression; open bars  interventional;
solid bars  diagnostic.




Percutaneous left atrial vent 9
Atrial septal stent 2






Restrictive bulboventricular foramen 1
Endomyocardial biopsy 5
Radiofrequency catheter ablation 3
Aortopulmonary collateral coil 2
Atrial septal defect device closure 1
Ventricular septal defect coil closure 1
Pulmonary artery catheter placement 1
Operative Interventions
Revision of surgical repair
Blalock-Taussig shunt revision 3
Thrombectomy (2 coronary, 1 right ventricle) 3





Arterial switch operation 2
Valve replacement 2
Stage 1 Norwood palliation 1
Coarctation repair 1
Atrial septal defect closure 1
Blalock-Taussig shunt 1
Surgical left atrial vent placement 1
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rates have steadily improved with our cumulative experi-
ence.
Diagnosis and subsequent interventions. In our series,
findings at catheterization frequently resulted in subsequent
patient interventions (83%). This was particularly notable in
patients placed on ECMO in the immediate post-operative
period, where 22 of 27 catheterizations (81%) led to
subsequent interventions. We maintain a high index of
suspicion of residual lesions in post-operative patients un-
able to be weaned from ECMO within 72 h of expected
myocardial recovery (5). Transthoracic echocardiography is
often limited in this setting, with less access to the standard
views and altered ventricular ejection because of reduced
preload while on ECMO. Catheterization during the
ECMO course can facilitate the diagnosis of residual lesions
that could limit successful weaning from ECMO. Early
catheterization and subsequent interventions may also facil-
itate recovery of myocardial function and reduce ECMO
duration, and thus the potential for ECMO-related com-
plications.
Another important subset of patients undergoing inter-
ventions at catheterization included those requiring left
heart decompression for severe ventricular dysfunction. This
facilitates adequate venous drainage and ECMO flows,
prevents over distension and injury of the systemic ventricle,
and reduces left atrial hypertension and associated pulmo-
nary edema. Balloon or blade atrial septostomy for left heart
decompression has been previously described (14). Biplane
fluoroscopy in the catheterization laboratory assists trans-
septal needle puncture required to decompress the left
atrium and place a vent or stent. Five patients who under-
went left heart decompression subsequently recovered ven-
tricular function and were successfully weaned and decan-
nulated from ECMO. In patients where the myocardium
did not recover after decompression, three were transplanted
from ECMO, and three were withdrawn from ECMO due
to severe neurological injury.
Our series of patients also includes a novel use of ECMO
to support two newborns with Ebstein’s anomaly and SVT
undergoing radiofrequency catheter ablation. Both infants
had a very unstable circulation while in their tachycardia.
The planned use of ECMO in these patients provided
stable circulatory support during the required stimulation of
SVT for intracardiac mapping and radiofrequency catheter
ablation. Both infants tolerated the procedure well and were
subsequently successfully decannulated.
Low risk of complications. Despite the logistical consid-
erations for hospital transport of patients on ECMO, and
the technical limitations of catheter-based interventions on
fully heparinized patients, our incidence of complications
was very low. The two complications we encountered
involved perforations of the left atrial appendage and the left
ventricular free wall, but both were well tolerated after a
percutaneous pericardial drain was placed. Despite systemic
heparinization, the perforations appeared to seal spontane-
ously before leaving the catheterization laboratory and did
not bleed thereafter. There were no access-related compli-
cations in any of the patients despite full heparinization
while on ECMO. Although we did not experience
transport-related complications, the transport of these pa-
tients from the ICU to the catheterization laboratory is
complex and labor-intensive involving nursing, ECMO
specialists, and physicians. Experienced personnel and care-
ful communication during patient transport facilitates the
safe movement of patients between the ICU, catheterization
laboratory, and OR without additional patient morbidity.
Improved survivals. Over our 17 years of experience sup-
porting cardiac patients with ECMO, the survival of pa-
tients we have catheterized on ECMO has been improving.
Our early survival to discharge was only 36% as compared
with our more recent survival to discharge of 56%. This
improvement likely reflects the difference in the time frame
and increasing experience with cardiac patients on ECMO,
the expansion of interventional catheterization techniques,
and broader indications for ECMO. Extracorporeal mem-
brane oxygenation has been increasingly used to support the
circulation not only in patients after cardiac surgery, but also
in patients with low cardiac output and cardiovascular
collapse as a bridge to transplantation. Six of our patients
with persistent myocardial dysfunction were successfully
transplanted after catheterization.
Study limitations. While the survival of patients catheter-
ized on ECMO has improved, our retrospective review
cannot definitively prove that this improvement is due to the
catheterization procedure. However, new information ob-
tained from catheterization likely contributed to better
outcomes. It would not be possible to determine prospec-
tively if catheterization on ECMO changes patient outcome
in a randomized, large-scale clinical study. Additionally,
because our patients catheterized on ECMO were so diverse
Figure 2. Survival of patients (n  54) catheterized on extracorporeal
membrane oxygenation over time. Solid bars  survivors; striped bars 
non-survivors.
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in their anatomical diagnoses, indications for ECMO, and
indications for catheterization on ECMO, it is impossible
to identify accurate risk factors to predict future patient
outcomes after catheterization on ECMO. The decision to
pursue catheterization on ECMO is made on an individual
case basis and is based on clinical judgment when the
potential for new information gained at catheterization
outweighs the risks of catheterization, and is believed to be
crucial to optimize patient outcome.
Conclusions. Cardiac catheterization on ECMO is an
important diagnostic tool for patients with a failing circu-
lation requiring ECMO support. Catheterization can be
performed safely with a low risk of complications and can
facilitate important therapeutic interventions. Cardiac cath-
eterization should be considered early in the ECMO course
to facilitate correction of residual lesions as well as to
support the failing myocardium with left heart decompres-
sion when indicated.
Reprint requests and correspondence: Dr. Karen L. Booth,
Critical Care Medicine Offices, 6th Floor, Children’s Hospital of
Philadelphia, 34th and Civic Center Boulevard, Philadelphia,
Pennsylvania 19104. E-mail: karenlbooth@msn.com.
REFERENCES
1. Kanter KR, Pennington DG, Weber TR, Zambie MA, Braun P,
Martychenko V. Extracorporeal membrane oxygenation for postoper-
ative cardiac support in children. J Thorac Cardiovasc Surg 1987;93:
27–35.
2. Delius RE, Bove EL, Meliones JN, et al. Use of extracorporeal life
support in children with congenital heart disease. Crit Care Med
1992;20:1216–22.
3. Dalton HJ, Siewers RD, Fuhrman BP, et al. Extracorporeal membrane
oxygenation for cardiac rescue in children with severe myocardial
dysfunction. Crit Care Med 1993;21:1020–8.
4. Black MD, Coles JG, Williams WG, et al. Determinants of success in
pediatric cardiac patients undergoing extracorporeal membrane oxy-
genation. Ann Thorac Surg 1995;60:133–8.
5. Duncan BW, Hraska V, Jonas RA, et al. Mechanical circulatory
support in children with cardiac disease. J Thorac Cardiovasc Surg
1999;117:529–42.
6. Baffes TG, Fridman JL, Bociff JP, Whitehill JL. Extracorporeal
circulation for support of palliative cardiac surgery in infants. Ann
Thorac Surg 1970;10:354–63.
7. Soeter JR, Mamiya RT, Sprague AY, McNamara JJ. Prolonged
extracorporeal oxygenation for cardiorespiratory failure after tetralogy
correction. J Thorac Cardiovasc Surg 1973;66:214–8.
8. ECMO Registry Report. Ann Arbor, MI: Extracorporeal Life Sup-
port Organization, July 2001.
9. Butler TJ, Yoder BA, Seib P, Lally KP, Smith VC. ECMO for left
ventricular assist in a newborn with critical aortic stenosis. Pediatr
Cardiol 1994;15:38–40.
10. Ward CJ, Mullins CE, Barron LJ, Grifka RG, Gomez MR, Cuellar-
Gomez MR. Use of extracorporeal membrane oxygenation to maintain
oxygenation during pediatric interventional catheterization. Am
Heart J 1995;130:619–20.
11. Ward KE, Tuggle DW, Gessouroun MR, Overholt ED, Mantor PC.
Transseptal decompression of the left heart during ECMO for severe
myocarditis. Ann Thorac Surg 1995;59:749–51.
12. Ettedgui JA, Fricker FJ, Park SC, Fischer DR, Siewers RD, del Nido
PJ. Cardiac catheterization in children on extracorporeal membrane
oxygenation. Cardiol Young 1996;6:59–61.
13. desJardins SE, Crowley DC, Beekman RH, Lloyd TR. Utility of
cardiac catheterization in pediatric cardiac patients on ECMO. Cathet
Cardiovasc Intervent 1999;46:62–7.
14. Seib PM, Faulkner SC, Erickson CC, et al. Blade and balloon atrial
septostomy for left heart decompression in patients with severe
ventricular dysfunction on extracorporeal membrane oxygenation.
Cathet Cardiovasc Intervent 1999;46:179–86.
1686 Booth et al. JACC Vol. 40, No. 9, 2002
Catheterization of Patients Supported by ECMO November 6, 2002:1681–6
